Quotient Sciences Header

Quotient Sciences Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Filters

Reset Filter

All Developments

Product Type

Companies

[{"company":"CSIR-Indian Institute of Chemical Technology","sponsor":"Marc Laboratories","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"CSIR-CDRI Signs Agreement with Marc Labs to Develop Drug for Heart Attack and Stroke","therapeuticArea":"Cardiology\/Vascular Diseases","highestDevelopmentStatus":"IND Enabling","country":"INDIA","productType":"Small molecule","productStatus":"New Molecular Entity","date":"June 2021","url1":"","url2":"","graph1":"Small molecule","graph2":"CSIR-Indian Institute of Chemical Technology"}]

CSIR-Indian Institute of Chemical Technology

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

CSIR-CDRI Signs Agreement with Marc Labs to Develop Drug for Heart Attack and Stroke

Details:

The agreement has been signed for the development of a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen induced platelet aggregation.

Lead Product(s): S007-867

Therapeutic Area: Cardiology/Vascular Diseases Product Name: S007-867

Highest Development Status: IND Enabling Product Type: Small molecule

Partner/Sponsor/Collaborator: Marc Laboratories

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement June 12, 2021

ASK
US

Upload
your Pipeline Activity

POST ENQUIRY